Results 71 to 80 of about 12,086 (172)

Surgical Delay for Hip Fracture Clients and the Use of Clopidogrel: An Integrative Review [PDF]

open access: yes, 2012
Hip fractures in elderly patients have very high postoperative mortality rates and the number of hip fractures in the United States is expected to increase exponentially before 2030.
Waller, Phoebe Genevieve
core  

Potentially inappropriate prescribing in nursing home residents detected with the community pharmacist specific GheOP3S-tool [PDF]

open access: yes, 2016
Background: The Ghent Older People’s Prescriptions community Pharmacy Screening (GheOP3S-)tool was recently developed to screen for potentially inappropriate prescribing (PIP).
Boussery, Koen   +7 more
core   +1 more source

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine

open access: yesMedical Devices: Evidence and Research, 2011
Ichiro Ikushima1, Kazuchika Yonenaga1, Hironao Iwakiri2, Hideki Nagoshi2, Haruhito Kumagai2, Yasuyuki Yamashita31Department of Radiology, 2Department of Cardiology, Miyakonojo Medical Association Hospital, Miyakonojo, Japan; 3Department of Diagnostic ...
Ikushima I   +5 more
doaj  

A terapêutica médica da angina de peito.

open access: yesActa Médica Portuguesa, 1997
The angina pectoris crisis should be treated with nitroglycerin S.L.. In our days as in the 19th century, the non pharmacological therapeutic approach for angina pectoris (per se and to improve the free interval between crises) is still the same.
J G Clara
doaj   +1 more source

Acute coronary disease Athero-Inflammation: Therapeutic approach [PDF]

open access: yes, 2003
Antithrombotic therapy is the cornerstone of the treatment of acute coronary syndromes, but there is now evidence which indicates that by blocking inflammation, thrombosis and thus, acute coronary events, could be lowered.
Altman Raul
core   +1 more source

Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?

open access: yesInternational Journal of Vascular Medicine, 2011
Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of patients undergoing coronary stenting. Clopidogrel has mostly replaced the use of ticlopidine due to its more favourable adverse event profile. However, also
Massimo Montalto   +7 more
doaj   +1 more source

Role of brain perfusion SPECT with 99mTc HMPAO in the assessment of response to drug therapy in patients with autoimmune vasculitis: a prospective study [PDF]

open access: yes, 2015
BACKGROUND: The diagnosis of vasculitis in the brain remains a quite difficult achievement. To the best of our knowledge, there is no imaging method reported in literature which is capable of reaching to a diagnosis of vasculitis with very high ...
Anna Margherita Maffione, 2   +11 more
core   +1 more source

Analysis of the structure of consumption of antiplatelet drugs in the Russian pharmaceutical market: 2014-2016

open access: yesКачественная клиническая практика, 2018
This article analyzes the volume of the Russian pharmaceutical market of antiplatelet drugs in the period 2014-2016. 80% of patients take clopidogrel generics, giving preference to Zilt®.
S. K. Zyryanov, E. V. Dumchenko
doaj  

Late coronary occlusion after intracoronary brachytherapy [PDF]

open access: yes, 1999
BACKGROUND: Intracoronary brachytherapy appears to be a promising technology to prevent restenosis. Presently, limited data are available regarding the late safety of this therapeutic modality.
Cervinka, P.   +9 more
core  

Is there a role for oral triple therapy in patients with acute coronary syndromes without atrial fibrillation? [PDF]

open access: yes, 2018
© 2018 Bentham Science PublishersBACKGROUND: Acute coronary syndrome (ACS) patients, despite treatment with dual antiplatelet therapy (DAPT), have up to 10% risk of recurrent major adverse cardiac events (MACE) in the short term.
Akhtar, Zaki   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy